Home > > > > > Report Detail

Global Parkinson's Disease Therapeutics Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 99
Inquire Before Buying

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of The disease.

The global Parkinson's Disease Therapeutics market was valued at US$ 2415 million in 2023 and is anticipated to reach US$ 3745.7 million by 2030, witnessing a CAGR of 6.0% during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for Parkinson's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Parkinson's Disease Therapeutics.

Report Scope

The Parkinson's Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Parkinson's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Parkinson's Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Merck

- Akorn

- GSK

- Novartis

- Boehringer Ingelheim

- Teva Pharmaceutical

- Abbvie

- Kyowa Hakko Kirin Pharma

- Astellas Pharma

- Roche

- H.Lundbeck

- Bausch Health

- Apokyn

- Orion

- Stada Arzneimittel

- US WorldMeds

- Desitin Arzneimittel

- Endo Pharmaceuticals

Segment by Type

- Sinemet-CR

- Trastal

- Madopar

- COMT Inhibitor

- Other

Segment by Application

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by companies in The industry, and The analysis of relevant policies in The industry.

Chapter 3: Detailed analysis of Parkinson's Disease Therapeutics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa Segment by country. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and capacity of each country in The world.

Chapter 11: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of The report.

Global Parkinson's Disease Therapeutics Market Research Report 2024

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2019-2030)
2.2 Parkinson's Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Parkinson's Disease Therapeutics Market Dynamics
2.3.1 Parkinson's Disease Therapeutics Industry Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2023
3.5 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2019-2030)
6.2 North America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Parkinson's Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2019-2030)
7.2 Europe Parkinson's Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Detail
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Detail
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Detail
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.9.5 Astellas Pharma Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.10.5 Roche Recent Development
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Detail
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.11.5 H.Lundbeck Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Detail
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.12.5 Bausch Health Recent Development
11.13 Apokyn
11.13.1 Apokyn Company Detail
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.13.5 Apokyn Recent Development
11.14 Orion
11.14.1 Orion Company Detail
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.14.5 Orion Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Detail
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.15.5 Stada Arzneimittel Recent Development
11.16 US WorldMeds
11.16.1 US WorldMeds Company Detail
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.16.5 US WorldMeds Recent Development
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Detail
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.17.5 Desitin Arzneimittel Recent Development
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Detail
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2019-2024)
11.18.5 Endo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Parkinson's Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Parkinson's Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Region (2019-2024)
Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Parkinson's Disease Therapeutics Market Share by Region (2025-2030)
Table 13. Parkinson's Disease Therapeutics Market Trends
Table 14. Parkinson's Disease Therapeutics Market Drivers
Table 15. Parkinson's Disease Therapeutics Market Challenges
Table 16. Parkinson's Disease Therapeutics Market Restraints
Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Parkinson's Disease Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2023)
Table 20. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Parkinson's Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Parkinson's Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Parkinson's Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Parkinson's Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Parkinson's Disease Therapeutics Product
Table 52. Merck Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Detail
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson's Disease Therapeutics Product
Table 57. Akorn Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Parkinson's Disease Therapeutics Product
Table 62. GSK Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson's Disease Therapeutics Product
Table 67. Novartis Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Detail
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 72. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Detail
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 77. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Detail
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson's Disease Therapeutics Product
Table 82. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Detail
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Detail
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 92. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Roche Company Detail
Table 95. Roche Business Overview
Table 96. Roche Parkinson's Disease Therapeutics Product
Table 97. Roche Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 98. Roche Recent Development
Table 99. H.Lundbeck Company Detail
Table 100. H.Lundbeck Business Overview
Table 101. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 102. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 103. H.Lundbeck Recent Development
Table 104. Bausch Health Company Detail
Table 105. Bausch Health Business Overview
Table 106. Bausch Health Parkinson's Disease Therapeutics Product
Table 107. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 108. Bausch Health Recent Development
Table 109. Apokyn Company Detail
Table 110. Apokyn Business Overview
Table 111. Apokyn Parkinson's Disease Therapeutics Product
Table 112. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 113. Apokyn Recent Development
Table 114. Orion Company Detail
Table 115. Orion Business Overview
Table 116. Orion Parkinson's Disease Therapeutics Product
Table 117. Orion Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 118. Orion Recent Development
Table 119. Stada Arzneimittel Company Detail
Table 120. Stada Arzneimittel Business Overview
Table 121. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 122. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 123. Stada Arzneimittel Recent Development
Table 124. US WorldMeds Company Detail
Table 125. US WorldMeds Business Overview
Table 126. US WorldMeds Parkinson's Disease Therapeutics Product
Table 127. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 128. US WorldMeds Recent Development
Table 129. Desitin Arzneimittel Company Detail
Table 130. Desitin Arzneimittel Business Overview
Table 131. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 132. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 133. Desitin Arzneimittel Recent Development
Table 134. Endo Pharmaceuticals Company Detail
Table 135. Endo Pharmaceuticals Business Overview
Table 136. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 137. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 138. Endo Pharmaceuticals Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Parkinson's Disease Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Sinemet-CR Features
Figure 4. Trastal Features
Figure 5. Madopar Features
Figure 6. COMT Inhibitor Features
Figure 7. Other Features
Figure 8. Global Parkinson's Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Parkinson's Disease Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Under 40 Years Old Case Studies
Figure 11. 40-65 Years Old Case Studies
Figure 12. Above 65 Years Old Case Studies
Figure 13. Parkinson's Disease Therapeutics Report Years Considered
Figure 14. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Parkinson's Disease Therapeutics Market Share by Region: 2023 VS 2030
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Players in 2023
Figure 18. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2023
Figure 20. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Parkinson's Disease Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Parkinson's Disease Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2019-2030)
Figure 34. China Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Parkinson's Disease Therapeutics Market Share by Country (2019-2030)
Figure 42. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2019-2030)
Figure 46. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 49. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 50. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 53. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 54. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 55. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 56. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 57. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 58. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 59. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 60. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 61. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 62. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 63. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 64. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 65. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs